MIR9-2HG and central nervous system cancer: LINC00461 (ECONEXIN) has been identified as a prognostic oncogene involved in tumor progression, also in gliomas, affecting cell proliferation, migration, and invasion via MAPK/ERK, PI3K/AKT, and other signaling pathways [26].